Over 90% adherence to relugolix in patients with Medicare with prostate cancer for 24 months supports its use as androgen ...
Intrommune Therapeutics, Inc. is excited to announce the publication of a its Phase 1 OMEGA (Oral Mucosal Escalation Goal Assessment) study evaluating the safety, tolerability, and adherence of a ...
Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for maintenance ...
Poor adherence to treatment is common despite various interventions aimed at improving treatment completion. Lack of a comprehensive and holistic understanding of barriers to and facilitators of ...
Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...
A low educational status was associated with longer delays before initiating treatment among relapsing-remitting MS patients ...
Achieve Life Sciences (ACHV) announced that the Data Safety Monitoring Committee, DSMC, has recently completed its second independent review of ...
By minimizing time spent in medical facilities, the subcutaneous version could improve treatment adherence and patients' quality of life. Dr. Eric K. Singhi shares his insights into the advantages of ...
Factors found to be significantly associated with anti-diabetic medication adherence were age >60 years (AOR = .276, 95% CI = .124-.611) attending higher education (AOR = 6.203, 95% CI = 1.775-21.93), ...
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results